CION Ameerpet
A breast biopsy is the only test that can confirm — or rule out — cancer for certain. A doctor removes a tiny sample of breast tissue so a pathologist can examine it under a microscope. Most biopsies are a short, day-care procedure done under local anaesthetic, and most results turn out non-cancerous. At CION Cancer Clinics in Hyderabad, every biopsy is image-guided for accuracy and reviewed by a tumor board — so you get a clear answer, not just a report. Your first consultation is free.
A breast biopsy is a procedure in which a doctor removes a small sample of tissue or cells from a suspicious area in the breast so that a pathologist can examine it under a microscope. It is the only test that can definitively confirm whether a breast change is cancer or not — a mammogram or ultrasound can point to a problem, but only a biopsy gives a certain answer.
Your doctor will recommend a biopsy when something needs to be checked closely: a lump you or a doctor can feel, a suspicious finding on a mammogram (such as a mass or microcalcifications), an abnormal area on a breast ultrasound or MRI (often a BI-RADS 4 or 5 result), persistent nipple discharge, or skin changes like dimpling or thickening.
It is important to keep this in perspective. Being sent for a biopsy is not a cancer diagnosis — about 75 to 80 percent of all breast biopsies turn out to be benign (non-cancerous). The purpose of the biopsy is to replace uncertainty with a clear answer, so that if treatment is needed it can start early, and if it is not needed you can be reassured for good.
Scans can flag a concern, but only a biopsy confirms or rules out cancer for certain by examining the actual tissue.
A felt lump, microcalcifications, a BI-RADS 4 or 5 scan, persistent nipple discharge or skin changes all warrant a closer look.
About 75 to 80 percent of breast biopsies are non-cancerous — a biopsy most often replaces worry with reassurance.
Being referred for a breast biopsy is not a cancer diagnosis. Across breast clinics, roughly 75 to 80 percent of all breast biopsies turn out to be benign — non-cancerous. A biopsy exists to settle uncertainty: for most women it ends in reassurance, and for the minority who do have cancer, it enables an early, accurate diagnosis — the single biggest advantage for successful treatment. Source: NCCN guidelines / peer-reviewed breast-clinic data.
There is no single "breast biopsy" — the right method depends on the size, location and nature of the finding. Your specialist chooses the least invasive technique that will still give a reliable answer. These are the main types, from the simplest needle test to a surgical biopsy.
The most common and preferred method. A hollow needle removes one or more small cylinders (cores) of tissue, usually under ultrasound guidance and local anaesthetic. Because it samples actual tissue, not just cells, it can tell invasive from non-invasive cancer and allows ER, PR and HER2 testing — so it is the workhorse for diagnosing a breast lump.
A gentle vacuum draws tissue into the needle, so several samples are collected through a single small insertion. It removes more tissue than a standard core needle, which improves accuracy for tricky targets like microcalcifications, and is often done under stereotactic (mammographic) or ultrasound guidance.
A minor surgical procedure that removes the entire lump or abnormal area, sometimes with a margin of normal tissue. It is used when needle biopsies are inconclusive or when a lesion needs to be fully removed. It is done in an operating theatre, often under local or light sedation.
A very thin needle draws out cells (not a tissue core) for cytology. It is quick, low-cost and useful for draining a cyst or sampling an enlarged lymph node, but it cannot tell invasive from in-situ cancer — so for a solid breast lump a core needle biopsy is usually preferred over FNAC.
A core needle biopsy is a same-day procedure — there is no general anaesthesia, no overnight stay, and most people are back to normal the next day. The needle insertion itself takes only a minute or two; the whole appointment, including imaging, usually runs 30 to 60 minutes. Here is exactly what happens, step by step.
You lie down and the radiologist uses ultrasound (or a mammogram for stereotactic biopsy) to locate the exact spot to be sampled and to guide the needle in real time.
The skin and breast tissue over the target are numbed with a local anaesthetic injection. You stay fully awake, but the area is numb — you should feel pressure, not pain.
A tiny nick is made in the skin and the biopsy needle is guided to the lesion. Several small cores of tissue are taken. You may hear a soft click or snapping sound from the spring-loaded device — this is normal.
A tiny, painless titanium marker clip may be placed at the site so the exact spot can be found again later if treatment or further imaging is needed. It is harmless and stays in place.
Pressure is applied to stop any bleeding, the small wound is closed with a steri-strip or small dressing (no stitches needed), and you rest briefly before going home. You can usually drive yourself if only local anaesthetic was used.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Confidential, doctor-led, and free for your first consultation. Call us on 1800-202-8726 or request a callback - we'll guide your next step.
The pathology report is the heart of the biopsy — it turns a tissue sample into the information your team needs to plan care. If the result is benign, the report names the harmless condition (such as a fibroadenoma or fibrocystic change) and usually that is the end of it. If cancer is found, the report describes it in detail, and these details directly shape treatment. Here is what each part means, in plain language.
The first and most important line: is the tissue non-cancerous (benign) or cancerous (malignant)? Most reports are benign. A clear benign result means no cancer treatment is needed — though your doctor may still advise follow-up depending on the finding.
If cancer is present, the report states whether it is in-situ (such as DCIS - ductal carcinoma in situ, contained within the duct and very treatable) or invasive (it has grown beyond the duct or lobule). This distinction is central to how the cancer is staged and treated.
The kind of cancer - most commonly invasive ductal carcinoma (IDC), which begins in a milk duct, or invasive lobular carcinoma (ILC), which begins in a milk-producing lobule. The type helps predict how the cancer tends to behave.
How abnormal the cells look and how fast they appear to be dividing. Grade 1 is slow-growing and looks close to normal tissue; grade 3 is faster-growing and more abnormal. Grade guides how aggressively the cancer is treated - it is not the same as stage.
Whether the cancer cells carry estrogen (ER) and progesterone (PR) receptors. If positive, the cancer is fuelled by these hormones - which is good news, because it means hormone (endocrine) therapy can be used as an effective, well-tolerated treatment.
Whether the cells over-produce the HER2 protein. HER2-positive cancers can grow faster but respond to powerful targeted anti-HER2 drugs. It is tested by IHC and, if borderline, confirmed by FISH - so a clear HER2 result is essential before treatment is planned.
An estimate of how many cells are actively dividing, given as a percentage. A higher Ki-67 (often above 30 percent) suggests a faster-growing tumour. It is one of several factors - alongside grade and receptor status - used to fine-tune the treatment plan.
This is the question most people worry about, and the honest answer is reassuring: a needle breast biopsy is not a painful procedure. Because the area is numbed with local anaesthetic, most patients describe feeling pressure rather than pain while the samples are taken. Tell your radiologist if you do feel any sharp pain — more anaesthetic can be given. Afterwards there may be mild soreness, easily managed with paracetamol.
Breast biopsy is a very safe, low-risk procedure, but like any procedure it has minor risks worth knowing about.
The most common after-effects. Core needle biopsies bruise more than fine needle ones, and a bruise can take a couple of weeks to fade. Soreness usually settles within a day or two.
A small amount of bleeding at the site is normal and stops with brief pressure. A larger collection of blood (haematoma) is uncommon and usually resolves on its own.
Infection is rare because the wound is tiny. Keeping the dressing clean and dry as advised keeps the risk very low; tell your team if the area becomes red, hot or increasingly painful.
Most people return to normal activities the same or next day. After a core needle biopsy it is sensible to avoid strenuous activity, heavy lifting and vigorous exercise for about 48 hours to limit bruising.
No. This is a common and understandable fear, but it is not supported by evidence. Modern biopsy techniques are safe and do not cause cancer to spread — and delaying a needed biopsy is far riskier than having one.
Waiting for results is often the hardest part, so it helps to know the timeline. For a routine breast biopsy, the pathology report is usually ready in about 3 to 7 days — sometimes sooner. The reason it is not instant is that the tissue has to be carefully processed, stained and examined by a pathologist; rushing this step risks an inaccurate answer, and getting it right matters more than getting it fast.
Some results take a little longer for good reason. If special tests are needed — such as immunohistochemistry (IHC) for ER, PR and HER2, or molecular and FISH testing — these add a few days because they are run as a second stage on a confirmed cancer. A clear, complete report that includes receptor status is far more useful for planning treatment than a quick, partial one.
At CION, we believe waiting in silence is not acceptable. Your report is not simply handed over — it is reviewed by our tumor board and explained to you by a specialist, so you understand exactly what it means and what the next step is. If anything is urgent, we fast-track it.
Cost is a fair and common question, and we believe in answering it openly. In Hyderabad, a breast biopsy typically costs between Rs. 3,500 and Rs. 15,000, depending on the type of biopsy, whether image guidance is used, and the pathology testing required. As a rough guide, a core needle biopsy sits at the lower end, while a vacuum-assisted or surgical (excisional) biopsy costs more because it involves more equipment or theatre time.
Two things are worth knowing. First, the histopathology (lab analysis) is usually charged separately from the procedure — and special tests like ER/PR/HER2 immunohistochemistry add to that. Second, the cheapest option is not always the right one: an accurate, complete result the first time avoids the cost and delay of a repeat. We practise transparent costs and no unnecessary tests — you will know what your biopsy involves and why before you commit to anything.
A clear, up-front cost for the biopsy and the pathology — no hidden add-ons, no tests you don't need.
Concessional diagnostic pricing for cancer patients, with expert-reviewed pathology reporting.
Cashless private insurance and EMI support available — our team helps you with the paperwork.
Your first consultation is free, so you can understand your options and costs before deciding.
A biopsy is only as good as the accuracy of the sample and the team that reads it. At CION Cancer Clinics, every breast biopsy is image-guided — ultrasound or stereotactic guidance places the needle exactly on the target — so we sample the right tissue the first time and reduce the chance of a repeat. The pathology is then reviewed by our tumor board, where medical, surgical and radiation oncologists look at your case together. That means decisions made by a team, not a single opinion, explained to you in an unhurried 45-minute consultation.
As a woman-headed organisation, breast and women's-health care sits at the heart of what we do, and our outcomes reflect it. CION patients see a 1-year breast cancer survival of 96.9 percent versus the national average of 85.4 percent — an 11.5 percentage-point difference.* If your biopsy is benign, we will tell you clearly and reassure you. If it shows cancer, we will walk every step of the path with you — calmly, transparently, and together.
A panel of 17 super-specialist oncologists across medical, surgical and radiation oncology.
Complex cases reviewed by 3+ specialists together — not one doctor's opinion.
A trusted network across Telangana and AP, rated 4.8/5 by patients on Google.
No unnecessary tests, transparent costs, and a free first consultation for all cancer patients.
*1-year survival. Source: ICMR / National Cancer Registry Programme (NCRP), compared with CION patient outcomes. CION figures are network outcomes; national figures are population averages and do not predict an individual's result.
From a worrying lump to a clear diagnosis and full breast cancer care - hear how our patients were guided with honesty, not pressure.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.No, a needle breast biopsy is not painful. The area is numbed with a local anaesthetic injection, so during the procedure most people feel pressure rather than pain. You stay awake and can tell the radiologist if you feel any sharp sensation, in which case more anaesthetic is given. Afterwards there may be mild soreness and some bruising for a few days, which is easily managed with simple painkillers like paracetamol. A surgical (excisional) biopsy involves a small cut and may use sedation, but it too is designed to keep you comfortable throughout.
For a routine breast biopsy, the pathology report is usually ready within about 3 to 7 days, and sometimes sooner. The tissue has to be carefully processed, stained and examined by a pathologist, which cannot be safely rushed. If special tests are needed — such as ER, PR and HER2 immunohistochemistry, or FISH and molecular testing on a confirmed cancer — these add a few more days. At CION, your report is reviewed by our tumor board and explained to you by a specialist rather than simply handed over, and anything urgent is fast-tracked.
A core needle biopsy (CNB) uses a hollow needle to remove small cylinders of actual tissue, while FNAC (fine needle aspiration cytology) uses a very thin needle to draw out individual cells. The key difference is that a core needle biopsy samples intact tissue, so it can tell invasive cancer from non-invasive (in-situ) disease and allows ER, PR and HER2 testing. FNAC is quicker and cheaper and is useful for draining a cyst or checking a lymph node, but for diagnosing a solid breast lump, a core needle biopsy is usually preferred because it gives more complete and reliable information.
No. This is a very common worry, but it is not supported by medical evidence. Modern biopsy techniques are safe and do not cause cancer to spread through the body. In fact, delaying or refusing a recommended biopsy is far riskier, because it can delay a diagnosis and the start of effective treatment. A biopsy simply removes a tiny sample so doctors can identify exactly what they are dealing with. The benefit of an accurate, early diagnosis vastly outweighs this unfounded fear.
In Hyderabad, a breast biopsy typically costs between Rs. 3,500 and Rs. 15,000, depending on the type of biopsy, whether image guidance is used, and the pathology testing required. A core needle biopsy is usually at the lower end, while vacuum-assisted and surgical biopsies cost more. The histopathology (lab analysis) is generally charged separately, and special tests such as ER/PR/HER2 add to the total. At CION we keep costs transparent and offer up to 50 percent off diagnostics for cancer patients, with expert-reviewed reports. Your first consultation is free — request a callback for an exact estimate.
The report first states whether the tissue is benign (non-cancerous) or malignant. Most are benign. If cancer is found, the report describes whether it is in-situ or invasive, the histologic type (such as invasive ductal carcinoma), the grade (1 to 3, how aggressive it looks), and the receptor status — ER, PR and HER2 — which decides whether hormone therapy or targeted anti-HER2 therapy will help. It may also include a Ki-67 score showing how fast cells are dividing. These details together guide your personalised treatment plan, which is why our team explains every part of the report to you.
Yes, a needle breast biopsy is a day-care procedure. It is done under local anaesthetic, takes only 15 to 20 minutes for the needle part, and you go home the same day with no overnight stay. If only local anaesthetic was used, you can usually drive yourself home. If you are given sedation — more common with a surgical biopsy — you should arrange for someone to drive you. It is sensible to avoid strenuous activity and heavy lifting for about 48 hours afterwards to limit bruising, but most people return to normal life the same or next day.
Preparation is usually simple. For a needle biopsy under local anaesthetic you do not normally need to fast. Tell your doctor about all medicines you take, especially blood thinners such as aspirin or warfarin, as you may be advised to pause them for a few days beforehand. On the day, avoid applying deodorant, powder, lotion or perfume to the breast and underarm, and wear a comfortable two-piece outfit and a supportive bra. If sedation or general anaesthesia is planned for a surgical biopsy, you will be told how long to fast. Your CION team will give you exact instructions for your specific procedure.
No. Being referred for a breast biopsy does not mean you have cancer. It simply means a finding needs to be checked to be certain. In fact, around 75 to 80 percent of all breast biopsies turn out to be benign — that is, non-cancerous. Doctors recommend a biopsy because imaging and examination alone cannot give a definite answer, and the only responsible step is to confirm one way or the other. For most women, a biopsy ends in reassurance. For the minority who do have cancer, an early, accurate diagnosis is the single best advantage for successful treatment.